Polish public radio covers the next wave of obesity drugs, focusing on Lilly's retatrutide and Novo's CagriSema.
Recap by typeshit. Full story at www.polskieradio.pl.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
A short clip from obesity doctor Nadolsky with his three pointers for people about to begin GLP-1 treatment. The details are in the video.
A quick list of foods like eggs, Greek yogurt, salmon, lentils and oats, which he says help with fullness and keeping muscle while losing weight.
ScienceAlert reports the rate among people who never took the drugs was 9%, a gap researchers say is worth investigating further.
Covers hair and nail findings, vision loss lawsuits both drugmakers dispute, and new WHO guidance against drug treatment for obesity in kids under 10.
Loading…